2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Clinical genetics<br />
matological anomalies . Almost 50% <strong>of</strong> patients with NS (sporadic or<br />
familial) carry an missense mutation <strong>of</strong> PTPN11 gene (12q24), while<br />
other genes ( KRAS and SOS1) play a minor role in the molecular<br />
pathogenesis <strong>of</strong> the disease .<br />
We present a familial case, mother and daughter, with NS diagnosed<br />
by used a scoring system based by clinical signs .<br />
The diagnosis was performed first in daughter, wich was identified at<br />
birth . She presented polihidramnyos, nuchal oedema and premature<br />
born . The patient was reevaluated <strong>of</strong> two months age . Clinical and<br />
paraclinic evaluation revealed the major features <strong>of</strong> NS: feeding difficulties<br />
with failure to thrive, short stature, typical facial dysmorphy (microcephaly,<br />
broad and high forehead, down-slanting palpebral fisusures,<br />
hypertelorism, epicanthic folds, micrognathia, low-set posteriorly<br />
rotated ears), short neck with excess nucal skin, pectus excavatum,<br />
Hypertrophic Obstructive Cardiomyopaty (HOMC) with asymmetrical<br />
septum hypertrophy and neuromotor retardation . Other feature was<br />
ombilical hernia . She had anemia, but no thrombocytopenia or other<br />
coagulation defect . Clinical genetic examination <strong>of</strong> mother (N .C .M .),<br />
31 years old, after delivery revealed the phenotype <strong>of</strong> NS (facial typical<br />
dysmorphysm, pterygium colli, pectus carinatum superior and excavatum<br />
inferior), pulmonar stenosis and mental retardation . The analysis<br />
<strong>of</strong> pedigree showed the absence <strong>of</strong> other cases in family .In conclusion,<br />
we emphasize, the importance <strong>of</strong> the clinical features for diagnosis,<br />
leading further to an aprropiate management and for according genetic<br />
counseling<br />
P01.179<br />
Noonan and cardio-facio-cutaneous syndromes: two clinically<br />
and Genetically Overlapping Disorders<br />
A. M. Nyström 1 , S. Ekvall 1 , E. Berglund 2 , M. Bjorkqvist 3 , G. Braathen 4 , K.<br />
Duchen 5 , H. Enell 6 , E. Holmberg 4 , U. Holmlund 7 , M. Olsson-Engman 8 , G. Annerén<br />
1 , M. L. Bondeson 1 ;<br />
1 Uppsala University, Uppsala, Sweden, 2 Central Hospital, Skelleftea, Sweden,<br />
3 University Hospial, Orebro, Sweden, 4 Sahlgrenska University Hospital, Gothenburg,<br />
Sweden, 5 University Hospital, Linkoping, Sweden, 6 Regional Hospital<br />
<strong>of</strong> Halmstad, Halmstad, Sweden, 7 Central Hospital, Vasteras, Sweden, 8 Regional<br />
Hospital <strong>of</strong> Karlskrona, Karlskrona, Sweden.<br />
Noonan and Cardio-facio-cutaneous (CFC) syndromes are related disorders<br />
associated with dysregulated RAS-MAPK signalling . Noonan<br />
syndrome (NS) is associated with mutations in the genes PTPN11,<br />
SOS1, KRAS and RAF1 . The genetic aetiology <strong>of</strong> the clinically overlapping<br />
CFC syndrome was recently assigned to four genes, BRAF,<br />
KRAS, MEK1 and MEK2 . Here, we present a comprehensive mutation<br />
analysis <strong>of</strong> BRAF, KRAS, MEK1, MEK2 and SOS1 in 31 unrelated NS/<br />
CFC patients without mutations in PTPN11. Mutations were identified<br />
in 8 patients, in whom we also present a detailed clinical investigation .<br />
Seven <strong>of</strong> the mutations were identified in patients with CFC diagnoses<br />
(2 in BRAF, 1 in KRAS, 1 in MEK1, 2 in MEK2 and 1 in SOS1) .<br />
Two mutations were novel: MEK1 E203Q and MEK2 F57L . The SOS1<br />
E433K mutation, identified in a patient diagnosed as CFC, has previously<br />
been reported in patients with NS . In one NS patient, we also<br />
identified a BRAF K499E mutation, previously reported in patients with<br />
CFC . We thus suggest involvement also <strong>of</strong> BRAF in the pathogenesis<br />
<strong>of</strong> NS .<br />
Taken together, our results indicate that the molecular and clinical<br />
overlap between CFC and NS is more complex than previously suggested<br />
and that the syndromes might even present as allelic disorders .<br />
Furthermore, we suggest that the diagnosis should be refined to, e.g.,<br />
NS-PTPN11-associated or CFC- BRAF-associated after the genetic<br />
defect has been established since this may have an impact on prognosis<br />
and treatment <strong>of</strong> the patients .<br />
P01.180<br />
clinical and molecular studies in 95 polish patients with noonan<br />
syndrome<br />
E. Obersztyn, J. Klapecki, M. Łaniewski -Wołłk, A. Szpecht - Potocka, J. Bal,<br />
T. Mazurczak;<br />
Institute <strong>of</strong> Mother and Child, Warsaw, Poland.<br />
Noonan syndrome (NS, OMIM 163950) is genetically heterogenous<br />
disorder characterized by facial dysmorphism, short stature, variety<br />
<strong>of</strong> heart defects (particularly pulmonary stenosis), chest deformations,<br />
pterygium colli, lymphatic dysplasia, cryptorchidism and psychomotor<br />
retardation . Heterogeneous mutations in PTPN11 gene are respon-<br />
sible for 29-60% <strong>of</strong> NS cases . The aim <strong>of</strong> our study was to estimate<br />
the frequency <strong>of</strong> PTPN11 gene mutations in Polish patients with NS .<br />
Results <strong>of</strong> clinical and molecular studies the group <strong>of</strong> 95 probands are<br />
reported . Detailed clinical evaluation, including family pedigree, dysmorphic<br />
features, pre- and postnatal development and congenital malformations<br />
is presented . Direct sequencing analysis <strong>of</strong> the 15 exons <strong>of</strong><br />
PTPN11 gene was performed and mutation was found in 32 (35%) <strong>of</strong><br />
the probands. The most frequent among 15 identified missense mutations<br />
were: 1510A>G and 922A>G . In 9(28%) patients mutation was<br />
familiar and in 77% <strong>of</strong> cases was maternal in origin .<br />
All patients with PTPN11 mutation demonstrated typical NS phenotype .<br />
Pulmonary valve stenosis, atrial septum defect, coagulation abnormalities,<br />
mild mental retardation, short triangular face with pointed chin<br />
were statistically the most frequent in patients with PTPN11 mutation .<br />
Statistically significant correlation <strong>of</strong> pulmonary stenosis with 922A>G<br />
and 1510A>G mutation was found . Heart defect was present in all probands<br />
with PTPN11 mutation, but only in 66% <strong>of</strong> their parents .<br />
We concluded that probably another mutations within SOS1, KRAS<br />
and BRAF genes involved in the RAS-MAPK pathway may be responsible<br />
for NS in subset <strong>of</strong> presented patients without PTPN11 mutation .<br />
Further investigations are planned to explain NS phenotype in these<br />
patients .<br />
P01.181<br />
sOs1 mutation as a cause for Noonan syndrome type 4: A report<br />
<strong>of</strong> two patients<br />
G. Yesil 1 , B. Tuysuz 1 , M. Zenker 2 ;<br />
1 Istanbul University, Cerrahpasa Faculty <strong>of</strong> Medicine, Istanbul, Turkey, 2 Universitatsklinikum<br />
Erlangen, <strong>Human</strong>genetisches Insitut, Erlangen, Germany.<br />
Noonan syndrome (NS) is an autosomal dominantly inherited disease<br />
characterized by mental retardation (25%), short stature, pterygium<br />
colli, congenital heart defect and hypogonadism . Approximately 50%<br />
<strong>of</strong> cases are caused by mutations in the PTPN11 gene on chromosome<br />
12q24 .1 . Recently, Roberts and Tartaglia (2007) found mutation<br />
in the SOS1 gene on chromosome 2p22 to be responsible from %20<br />
<strong>of</strong> NS who had ectodermal abnormalities but normal development .<br />
This subtype called NS4 which share many clinical features with a<br />
group <strong>of</strong> developmental disorders including Costello and CFC (Cardi<strong>of</strong>aciocutenous)<br />
syndrome. Our first patient was a 7 month old male<br />
and the second was 45 days old girl who had coarse face, sparse hair<br />
and eyebrows and skin loss . Valvular pulmonary stenosis was shown<br />
in echocardiography at the first patient and atrioventricular channel<br />
defect and pulmonary hypertension at the second . One <strong>of</strong> our patients<br />
had signs <strong>of</strong> hyperkeratotic skin too . SOS 1 mutation were detected on<br />
exon 6; c .797C-> A heterozygous, p .T266K and on exon16 c .2536G>A<br />
heterozygous p .E846K in patient 1 and patient 2 respectively . Pulmonary<br />
stenosis was found more frequently in patients with SOS1 mutations<br />
than PTPN1 mutations and atrial septal defect was relatively rare<br />
in affected individuals with SOS1 mutations . Thus clinical examination<br />
can be indeterminative . It is important to remember to identify SOS1<br />
gene on patients who are free <strong>of</strong> BRAF, KRAS, MEK 1, 2 mutations<br />
that are responsible from the etiology <strong>of</strong> CFC syndrome .<br />
P01.182<br />
Prenatal images and evolution to cutis verticis gyrata in a<br />
newborn with Noonan syndrome<br />
A. Moresco 1 , J. van der Velde 2 , M. Ingilde 2 , G. Chernovetzky 2 , S. Naddeo 2 , S.<br />
Spinelli 2 , M. Rittler 2 ;<br />
1 Centro Nacional de Genética Médica, Buenos Aires, Argentina, 2 Grupo de<br />
Diagnóstico Prenatal. Hospital Materno Infantil Ramón Sardá, Buenos Aires,<br />
Argentina.<br />
Cutis verticis gyrata (CVG) is a rare defect, characterized by skin ridges<br />
and<br />
furrows forming cerebriform folds . Its primary form is associated with<br />
neuropsychiatric disorders or genetic syndromes, such as Turner and,<br />
more rarely, Noonan . Secondarily, CVG may be due to a local process<br />
or a systemic illness .<br />
Objective: To show the prenatal images <strong>of</strong> CVG in a fetus, and its<br />
evolution until birth, when Noonan syndrome was diagnosed .<br />
case report: The propositus was the third child <strong>of</strong> a young and healthy<br />
couple . Pregnancy was uneventful until 18 gestational weeks, when an<br />
ultrasound (US) scan revealed a cystic hygroma, hydrothorax and a<br />
fluid collection at the cephalic pole, which first suggested an underlying